Auda increases stake in Amadeus II

Amadeus II is a 2000-vintage fund which still owns home screen marketing company Celltick and imaging equipment company Teraview.

Auda International has increased its stake in Amadeus Capital’s $335 million Fund II, according to UK regulatory notices.

Auda most recently bought a stake in the 2000-vintage fund from LMS Capital, which has been in realisation since 30 November 2011. The London-based investment firm formerly invested in small- and medium-sized companies in the business, consumer and energy sectors, according to its website.

Previously Auda purchased an interest in the fund from European charitable foundation The Wellcome Trust, which sold its stake as part of a $750 million portfolio of other venture capital funds.

Auda did not return a request for comment but according to UK regulatory filings the firm funded both transactions using its $322 million Auda Secondary Fund III.

Amadeus II made growth equity investments in Western Europe, targeting the clean energy, e-commerce, hardware and software technology, media and medical industries.

In 2005, Amadeus led an $11 million investment round in home screen marketing company Celltick Technologies and in 2004 it invested £6 million ($9.2 million; €8.2 million) in Cambridge-based imaging equipment company Teraview. Both companies remain in Amadeus’ portfolio, according to the firm’s website.

A spokesperson from Amadeus did not return a request for comment by press time.